Beikong Medical Health Industry Group Co., Ltd. issued a good news. Based on the preliminary assessment of the available information, it is expected that the interim results for the six months ended June 30, 2018 will be significantly reduced compared to the losses for the same period last year. The changes are mainly due to the combined effects of the following factors:

1. The Group's main business income and gross profit increased by approximately 67% and 73% respectively, benefiting from the favorable development of the People's Republic of China's major health market;

2. The Group recorded a net sales gain of approximately HK$15 million for the sale of a non-wholly owned subsidiary of net debt during the period;

3. Interest income generated from loans lent for strategic planning of idle funds increased by approximately HK$16.9 million as compared with the same period last year;

4. The fair value of the investment properties of the Group's investment properties in Shanghai and Beijing increased by a total of not less than HK$71 million compared to the same period last year.

China's big health industry is booming and there is huge room for development. The Group is committed to the construction and development of a large health service system, which is in line with the Chinese government's policy of supporting the development of a healthy industry, laying out a large health industry chain and deepening the health segment. Therefore, the Group believes that it will have broad development prospects in the future.